Janssen, Galapagos To Develop Oncology Targets
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal valued at up to $15.5 million is the first in the oncology field for Galapagos’ BioFocus DPI service divison.
You may also be interested in...
Bausch & Lomb Collaborates With Galapagos On Ophthalmic Disease Candidates
Eye health company joins long list of pharmaceutical firms partnering with Galapagos in past year.
Bausch & Lomb Collaborates With Galapagos On Ophthalmic Disease Candidates
Eye health company joins long list of pharmaceutical firms partnering with Galapagos in past year.
GSK Links With OncoMed, Galapagos To Boost Oncologic, Anti-Infective Pipelines
Deals present possible $1.4 billion for OncoMed, €245 million for Galapagos through GSK’s external drug discovery centers.